news.financial
Commented by Stefan Bode on October 30th, 2026 | 08:49 CET
Stock Market Tensions: Margin Pressure, a Commodity Boom and Shifting Guidance – Cancom, Deutsche Rohstoff and Power Metallic Mines
Created and published on behalf of Power Metallic Mines.
International capital markets are currently caught between macroeconomic headwinds from sharply rising interest rates and lucrative, targeted opportunities. While restraint in corporate investment is forcing established providers to exercise strategic cost discipline, the global race for critical raw materials and key metals is driving exploration projects forward at a rapid pace. At the same time, a higher energy price environment and strategic gains from equity holdings at commodity producers are leading to surprisingly dynamic upward earnings revisions. Investors once again face the challenge of separating merely temporary one-off effects from sustainable operating earnings power.
Read
Commented by Jens Castner on October 30th, 2026 | 05:45 CET
When the stock market gets it wrong: Schott Pharma clears its name; Lahontan Gold and Instone are the next candidates
Markets are quick to judge, and often paint companies with a broad brush. When one company runs into difficulties, its competitors immediately come under suspicion too. Schott Pharma has already been through this and dispelled the doubts with strong figures. Its share price is recovering. For Lahontan Gold and Instone Real Estate, the recovery has yet to come. The Canadian gold explorer is being punished alongside the major producers, while the property developer is being grouped with Berlin's residential landlords. In both cases, the facts tell a different story. The share price upside is considerable.
Read
Commented by Nico Popp on October 30th, 2026 | 05:43 CET
Antimony Countdown: BASF Needs New Supplies as Perpetua Resources and NSJ Antimony Develop North American Sources
Created and published on behalf of NSJ Antimony
On November 27, 2026, China's suspension of its antimony export ban to the United States is due to expire. Without an extension by Beijing, US buyers risk losing access to this metalloid, which is essential for flame retardants and armaments. This was reported by industry publication Mining Weekly. According to market information provider Fastmarkets, antimony was trading at USD 18,300 to USD 19,000 per tonne in Rotterdam in mid-October. This is well below the all-time high of approximately USD 59,750 reached in summer 2025. However, the West's dependence on Chinese refineries remains unchanged.
Read
Commented by Armin Schulz on October 30th, 2026 | 05:42 CET
BYD, Globex Mining, Rio Tinto – Humanoid Robots Set to Fuel Demand for Raw Materials
A humanoid robot consists of more than just software. This is illustrated by a design patent the Chinese patent office published on October 9 for a BYD robot. Two arms, two legs and movable fingers need motors, batteries and cables, which means plenty of metal. If the automaker moves into series production, it could further boost demand for metals such as copper and lithium. The Chinese group is not alone in this, as Tesla, Hyundai, Xiaomi and others are also working on it. This development also benefits raw materials companies, from mining groups to royalty companies with broad portfolios. Today we take a closer look at BYD, Globex Mining and Rio Tinto.
Read
Commented by Matthias Schomber on October 30th, 2026 | 05:40 CET
AI Boom and Energy Transition: How Infineon, SK hynix and RE Royalties Could Transform Almost Every Retail Investor's Portfolio!
Artificial intelligence is a major driver of the semiconductor industry, fuelled by the growing demand for data centres. This has recently propelled the share prices of companies such as Infineon and SK hynix to extraordinary levels, before a correction set in as some stocks multiplied in value within just a few months. At current levels, and with fresh figures available, this could be an attractive entry opportunity if a few things are considered. In this article, we examine not only these two semiconductor stocks but also RE Royalties, a niche specialist in clean energy financing. We explore how German semiconductor specialist Infineon is driving efficiency through its chip technologies, why South Korean memory giant SK hynix is reshaping the sector with exceptionally strong margins, and why royalty pioneer RE Royalties could be on the verge of a technical breakout following a possible bottoming-out. We examine the financial data, strategic opportunities and risks associated with each company.
Read
Commented by André Will-Laudien on October 30th, 2026 | 05:39 CET
AI, robotics and e-mobility - bring on the year-end rally! Alphabet, Stellantis, First Hydrogen and Ubtech Robotics in focus
Despite the megatrends of artificial intelligence, robotics and e-mobility, the Q3 reporting season is delivering major surprises on both the positive and negative sides. For investors, high-tech trends are rapidly merging into a technological super-wave that shows no mercy on reporting days either. Alphabet loses 13% in 24 hours, while ServiceNow loses as much as 26% - good charts quickly look bad again. But healthy consolidation phases in autumn are never in short supply; in recent years, the only question has been: When to jump back in? According to current analyst statements, the massive earnings upgrades will continue into 2027 and beyond. Highly automated companies are already reporting significant margin increases, underpinning strong structural growth. Observers therefore welcome the temporary deflation, as these are usually buying levels for good stocks. Institutional investors are already using current valuations to selectively add highly scalable technology stocks to their portfolios. Those who analyse carefully will discover the right medium-term entry points even amid high volatility.
Read
Commented by Nico Popp on October 30th, 2026 | 05:37 CET
Methane Regulation: ExxonMobil Issues Warning, EQT Expands Exports and Zefiro Methane Scales Up Well Remediation
Created and published on behalf of Zefiro Methane Corp.
Reducing methane emissions is becoming an increasingly important political priority on both sides of the Atlantic. While the European Union and international gas producers negotiate deadlines for new import regulations, the United States is accelerating the remediation of abandoned wells. With substantial government funding, a lucrative market is emerging for specialist environmental service providers. Zefiro Methane is at the centre of this development, rapidly expanding its operations across North America with fresh capital and new framework agreements.
Read
Commented by Stefan Feulner on October 30th, 2026 | 05:33 CET
DEUTZ, dynaCERT, Cummins: The diesel engine is far from dead
Diesel engines should have been in decline long ago. Yet on construction sites, in mines and in international freight transport, the reality is different. Heavy machinery must operate reliably, even where charging infrastructure is lacking and downtime costs thousands of euros. That is why engine manufacturers continue to invest in more efficient internal combustion engines, while retrofit specialists aim to reduce fuel consumption across existing fleets. For investors, this creates a contrast: multibillion-dollar corporations are developing new generations of engines, while smaller technology providers are seeking to build businesses around the millions of diesel engines already in service.
Read
Commented by Lars Winter on October 30th, 2026 | 05:31 CET
Good news from Almonty, record profits at Deutsche Bank and a cloud boom at Microsoft and SAP: Four promising stocks under review
Tungsten specialist Almonty is finally getting the long-awaited supply of this strategically important raw material to the West underway. Deutsche Bank reports record profits, Microsoft turns the cloud and AI boom into growing earnings and SAP impresses with strong cloud growth and rising profitability. On the stock market, however, investors are rewarding these advances very differently. Between a halved share price, a low earnings valuation and high growth expectations, the intriguing question is where the greatest opportunities lie now and how much confidence is already priced in. We take a closer look at the four promising stocks in our stock review.
Read
Commented by Matthias Schomber on October 30th, 2026 | 05:27 CET
BioNTech seeks a breakthrough with its cancer pipeline, DroneShield battles short sellers and Cardiol Therapeutics targets a rebound!
Created and published on behalf of Cardiol Therapeutics
Biotech heavyweights such as BioNTech and defence and drone stocks such as DroneShield are currently looking for unambiguous and clear trend signals. While BioNTech is grappling with clinical setbacks and internal discussions despite strategic collaborations, defence specialist DroneShield is weighed down by persistent short-selling pressure and rather subdued growth expectations. At the same time, Cardiol Therapeutics is coming into focus as a technically promising candidate that, following a correction lasting several months, could now find the long-awaited bottom at a prominent technical support zone. This equity analysis of the 3 stocks examines the financial data, operational milestones and strategic opportunities as well as the risks of the three companies to provide guidance that is as well-founded as possible. Read on to find out where attractive opportunities are now emerging.
Read
Commented by Armin Schulz on October 29th, 2026 | 05:43 CET
Almonty Industries, Rheinmetall and SpaceX: Tungsten as the backbone of armaments and spaceflight
Rearmament begins in the mine, not the factory. According to the September Position Paper from the German Mechanical Engineering Industry Association (VDMA), raw materials such as tungsten are indispensable in armaments, aviation and many other sectors. The close link between defence and space became clear on October 1. That day, Rheinmetall Italia and Argotec launched their first joint satellite for military airspace surveillance aboard a SpaceX Falcon 9. Raw materials, defence and spaceflight all depend on the same supply chain. Companies that can close critical gaps are in demand. We therefore take a closer look at Almonty Industries, Rheinmetall and SpaceX.
Read
Commented by Jens Castner on October 29th, 2026 | 05:40 CET
A Breakout in the Making? Desert Gold Ventures and Oklo following in Moderna's footsteps
Created and published on behalf of Desert Gold Ventures.
Moderna has already made the big leap. Yet the best trial data in the company's history sent the shares tumbling, because the success was already priced in. The situation is different for two stocks that have also reached crucial milestones but still attract little attention on the stock market. Desert Gold Ventures is on the verge of its first gold production in Mali. Nuclear power specialist Oklo has commissioned its first reactor, but still needs a little more time before its commercial breakthrough. Analysts' price targets for both shares are several times their current prices.
Read
Commented by André Will-Laudien on October 29th, 2026 | 05:39 CET
Life Sciences in Focus as Sector Rotation Takes Shape: Bayer, Vidac Pharma, Eli Lilly, Novo Nordisk and Evotec in 2027
AI is consolidating, and the Life Sciences sector is firing up its first turbo: Rising healthcare spending, the demographic ageing wave and a veritable wave of innovation are catapulting the industry straight into a multi-year supercycle – and now the major players are reallocating their capital. AI and high-tech have delivered their returns, and now the new outperformers for 2027 are stepping into the spotlight. The catch: after years of heavy losses, most stocks are trading close to their 5-year lows. That will not last! Some companies are already waiting in the wings, with the painful restructuring completed. Leading the way, Novo Nordisk continues its relentless advance as the undisputed flagship of the global obesity and diabetes wave. A genuine hidden gem for return hunters is Vidac Pharma. Through its research into the Warburg effect, the biotech firm is revolutionising cancer therapy and, as a classic high-beta play, adds a dash of spice to opportunity-focused portfolios. The giant Bayer is also back, consistently using the current valuation lull as a major entry opportunity to ignite the next phase of growth with a revamped pipeline. The power quartet is completed by Hamburg-based drug discovery company Evotec, which benefits directly from demand for complex therapies as an indispensable infrastructure and development partner. Those who want to stay ahead in the coming Life Sciences boom need to set the course for their portfolio now!
Read
Commented by Stefan Feulner on October 29th, 2026 | 05:36 CET
thyssenkrupp, Strategic Resources and Cleveland-Cliffs: Europe's Steel Challenge Becomes a Stock Market Opportunity
Europe's steel industry faces a difficult balancing act. More climate-friendly production processes require billions in investment, while high energy costs and international competition weigh on margins. Policymakers are calling for industrial transformation, but without reliable financing, affordable hydrogen and suitable raw materials, many projects risk stalling. Meanwhile, the recovery of US steelmakers shows how quickly earnings can improve with better market conditions. On the stock market, attention is therefore turning not only to established producers, but also to companies seeking to supply the raw materials needed for the next generation of steel production.
Read
Commented by Carsten Mainitz on October 29th, 2026 | 05:31 CET
Gold, Tickets, Turnarounds! Why Stock Pickers Should Take a Closer Look at DRC Gold, CTS Eventim and Mutares Now
The stock market is no petting zoo. Investors seeking returns have to go hunting themselves. Stock picking is the art of finding tomorrow's winners before the rest of the market wakes up. Under the leadership of industry veteran Klaus Eckhof, DRC Gold is working to take a stake in a gold project in the northeast of the Democratic Republic of the Congo. This could take the company to a whole new level. CTS Eventim is attracting renewed attention thanks to an activist investor. This could boost the share price. Mutares has many irons in the fire. Who is ahead?
Read